Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse.

@article{Bchner1991RecombinantHG,
  title={Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse.},
  author={Th. B{\"u}chner and Wolfgang Hiddemann and Michael Koenigsmann and M Zuehlsdorf and Bernhard Josef W{\"o}rmann and Anja B{\"o}ckmann and Emilio Freire and Georg Innig and Georg Maschmeyer and Wolf Dieter Ludwig},
  journal={Blood},
  year={1991},
  volume={78 5},
  pages={
          1190-7
        }
}
To reduce critical neutropenia after chemotherapy (CT) for acute myeloid leukemia (AML) we administered recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) to patients over the age of 65 years with newly diagnosed AML and to patients with early or second relapse. CT was 9-day 6-thioguanine, ara-C, and daunorubicin (TAD9) in newly diagnosed AML and sequential high-dose ara-C and mitoxantrone (S-HAM) for relapse. In patients whose bone marrow was free from blasts a… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS, ESTIMATED 57% COVERAGE

53 Citations

0510'93'98'04'10'16
Citations per Year
Semantic Scholar estimates that this publication has 53 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 45 REFERENCES

Different responsiveness of Ah4L blasts to rhGM-CSF pre and post chemotherapy

  • M Zuhlsdorf, W Hiddemann, M Koenigsmann, B Wormann, U Biichter, Th Biichner
  • Proc Am Assoc Cancer Res
  • 1991

Similar Papers

Loading similar papers…